Obtaining a better understanding of how ATF3 modulates metabolic, immuno-responsive, and oncogenic signaling pathways could pave the way for the transcription factor to become an intriguing target for the treatment of metabolic dyshomeostasis, immune disorders, and various cancers. Here, ATF3 is linked to cancer.